989
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa

, , , , , & show all
Article: 2350232 | Received 17 Mar 2024, Accepted 24 Apr 2024, Published online: 09 May 2024

Figures & data

Table 1. Summary of the key considerations for each step of B-VEC application.